These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 25445503)
1. Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer. Xu X; Tang X; Lu M; Tang Q; Zhang H; Zhu H; Xu N; Zhang D; Xiong L; Mao Y; Zhu J Exp Mol Pathol; 2014 Dec; 97(3):579-84. PubMed ID: 25445503 [TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma. Han L; Jiang B; Wu H; Zhang S; Lu X Int J Clin Exp Pathol; 2014; 7(10):6734-42. PubMed ID: 25400753 [TBL] [Abstract][Full Text] [Related]
3. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study. Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695 [TBL] [Abstract][Full Text] [Related]
4. Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer. Lin H; Huang JF; Qiu JR; Zhang HL; Tang XJ; Li H; Wang CJ; Wang ZC; Feng ZQ; Zhu J Exp Mol Pathol; 2013 Feb; 94(1):73-8. PubMed ID: 23031786 [TBL] [Abstract][Full Text] [Related]
5. Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma. Pula B; Jethon A; Piotrowska A; Gomulkiewicz A; Owczarek T; Calik J; Wojnar A; Witkiewicz W; Rys J; Ugorski M; Dziegiel P; Podhorska-Okolow M Histopathology; 2011 Dec; 59(6):1249-60. PubMed ID: 22175904 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of melanoma-associated antigen A9 in renal cell carcinoma. Hatiboglu G; Pritsch M; Macher-Goeppinger S; Zöller M; Huber J; Haferkamp A; Pahernik S; Wagener N; Hohenfellner M Scand J Urol; 2013 Aug; 47(4):311-22. PubMed ID: 23140095 [TBL] [Abstract][Full Text] [Related]
7. High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma. Gu X; Fu M; Ge Z; Zhan F; Ding Y; Ni H; Zhang W; Zhu Y; Tang X; Xiong L; Li J; Qiu L; Mao Y; Zhu J Sci Rep; 2014 Oct; 4():6625. PubMed ID: 25315972 [TBL] [Abstract][Full Text] [Related]
8. Upregulated IL-19 in breast cancer promotes tumor progression and affects clinical outcome. Hsing CH; Cheng HC; Hsu YH; Chan CH; Yeh CH; Li CF; Chang MS Clin Cancer Res; 2012 Feb; 18(3):713-25. PubMed ID: 22186257 [TBL] [Abstract][Full Text] [Related]
9. MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis. Yang F; Zhou X; Miao X; Zhang T; Hang X; Tie R; Liu N; Tian F; Wang F; Yuan J Breast Cancer Res Treat; 2014 May; 145(1):23-32. PubMed ID: 24687377 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer. Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma. Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477 [TBL] [Abstract][Full Text] [Related]
12. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue. Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617 [TBL] [Abstract][Full Text] [Related]
13. High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma. Zhai X; Xu L; Zhang S; Zhu H; Mao G; Huang J Oncotarget; 2016 Jan; 7(4):4871-81. PubMed ID: 26717042 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of MAGE-A9 expression in patients with colorectal cancer. Zhan W; Zhang Z; Zhang Y; Ma J; Wu T; Gu Y; Li Y; Yang J Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):239-45. PubMed ID: 26516058 [TBL] [Abstract][Full Text] [Related]
15. High expression of MAGE-A9 is associated with unfavorable survival in esophageal squamous cell carcinoma. Qi Y; Cao KX; Xing FC; Zhang CY; Huang Q; Wu K; Wen FB; Zhao S; Li X Oncol Lett; 2017 Sep; 14(3):3415-3420. PubMed ID: 28927095 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer. Xu Y; Wang C; Zhang Y; Jia L; Huang J Sci Rep; 2015 Jul; 5():12104. PubMed ID: 26175056 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer. Bernardi MA; Logullo AF; Pasini FS; Nonogaki S; Blumke C; Soares FA; Brentani MM Oncol Rep; 2012 Jan; 27(1):28-38. PubMed ID: 21956537 [TBL] [Abstract][Full Text] [Related]
18. Increased Brahma-related Gene 1 Expression Predicts Distant Metastasis and Shorter Survival in Patients with Invasive Ductal Carcinoma of the Breast. Do SI; Yoon G; Kim HS; Kim K; Lee H; Do IG; Kim DH; Chae SW; Sohn JH Anticancer Res; 2016 Sep; 36(9):4873-82. PubMed ID: 27630343 [TBL] [Abstract][Full Text] [Related]
19. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329 [TBL] [Abstract][Full Text] [Related]
20. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Di Saverio S; Gutierrez J; Avisar E Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]